Lubiprostone as a potential therapeutic agent to improve intestinal permeability and prevent the development of atherosclerosis in apolipoprotein E-deficient mice.
Open Access
-
- ISHIGAMI Tomoaki
- 横浜市立大学
Bibliographic Information
- Title
- Lubiprostone as a potential therapeutic agent to improve intestinal permeability and prevent the development of atherosclerosis in apolipoprotein E-deficient mice.
- Author
- Kentaro Arakawa, Tomoaki Ishigami, et al.
Journal
-
- PLoS One
-
PLoS One 14 2019
